Inhalation Sedatives Market Report 2026

Inhalation Sedatives Market Overview

• Inhalation Sedatives market size has reached to $2.43 billion in 2025 • Expected to grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Impact Of Rising Healthcare Expenditure On The Market Growth Due To Increased Surgeries And Advanced Anesthesia Adoption • Market Trend: Innovations In Inhalation Sedatives Market Enhancing Patient Comfort And Safety • North America was the largest region in 2025.

What Is Covered Under Inhalation Sedatives Market?

Inhalation sedatives refer to a relaxing agent used with a nose mask. In high doses, inhalation sedatives can be used as a general anesthetic, a calming agent, and to treat sleep disorders. Inhalation sedation is the continuous administration of a tranquilizer through a nose mask. The method has also been referred to as ‘happy gas’, ‘laughing gas’, or ‘conscious sedation’. The gas is known as nitrous oxide. The main types of products in the inhalation sedatives market are sevoflurane, desflurane, isoflurane, and nitrous oxide. Sevoflurane is a sweet-smelling, nonflammable, extremely fluorinated methyl isopropyl ether that is utilized as an inhalational anesthetic for general anesthesia induction and maintenance. The different applications include induction, and maintenance and involve various sectors such as hospitals, ambulatory surgical centers, and others.

What Is The Inhalation Sedatives Market Growth Forecast?

The inhalation sedatives market size is expected to see strong growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to development of new inhalation anesthetic agents, expansion of ambulatory surgical services, rising adoption of sedation monitoring technologies, integration of AI-based anesthesia management, growing demand for pediatric and outpatient sedation procedures. Major trends in the forecast period include rising adoption of inhalation sedatives in pediatric and adult surgeries, increased use of nitrous oxide for dental analgesia and minor procedures, growth in outpatient and ambulatory surgical centers utilizing sedation, integration of sedation techniques in pain management and anxiety reduction, focus on safety protocols and monitoring standards during sedation.

Global Inhalation Sedatives Market Segmentation

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide 2) By Application: Induction, Maintenance 3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Sevoflurane: Pediatric Anesthesia, Adult Anesthesia 2) By Desflurane: Outpatient Surgery, Maintenance Anesthesia 3) By Isoflurane: Maintenance Of General Anesthesia, Induction Of General Anesthesia 4) By Nitrous Oxide: Analgesia For Dental Procedures, Anesthesia For Minor Surgical Procedures

What Are The Drivers Of The Inhalation Sedatives Market?

The rising healthcare expenditure is expected to propel the growth of the Inhalation Sedatives market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure increases the use of inhalation sedatives by supporting more surgeries, advanced anesthesia equipment, improved patient access, and enhanced R&D for safer, more effective sedatives. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the Inhalation Sedatives industry. The increasing prevalence of respiratory diseases is expected to propel the growth of inhalation sedatives going forward. Respiratory diseases are medical conditions that affect the respiratory system, which include the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Inhalation sedatives are used in the management of respiratory diseases to achieve various goals, including reducing anxiety, improving patient comfort, facilitating medical procedures, and helping to improve breathing and overall respiratory function For instance, in December 2023, according to the National Center for Biotechnology Information, a US-based government agency, the number of COPD cases was expected to rise by 112 million, reaching a total of 592 million by 2050, which would represent 9.5% of the eligible population. Therefore, the increasing prevalence of respiratory diseases will drive the future inhalation sedatives industry.

Key Players In The Global Inhalation Sedatives Market

Major companies operating in the inhalation sedatives market are AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals plc, Jiangsu Hengrui Medicine Co. Ltd., Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Torrent Pharmaceuticals Ltd., Aurobindo Pharma Limited, Intas Pharmaceuticals Ltd., Wockhardt Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Life Sciences Limited

Global Inhalation Sedatives Market Trends and Insights

Major companies operating in the inhalation sedatives market are developing innovative services, such as inhalation sedation service, to improve patient comfort. Inhalation sedation service is a safe and effective technique that uses sedative gases to help reduce anxiety and discomfort during dental procedures. For instance, in November 2023, Platinum Dental Services, a Ghana-based dental services provider, launched an inhalation sedation service is a dental approach aimed at improving patient comfort through the administration of a blend of sedative gases inhaled during procedures. This technique effectively reduces anxiety and fear related to dental visits, making it especially helpful for both adults and children who may feel nervous about receiving dental care. By creating a safe and controlled atmosphere, inhalation sedation enables patients to stay relaxed while remaining aware and responsive during treatments, thus fostering a positive dental experience. This innovative service seeks to enhance overall patient care and motivate individuals to pursue essential dental treatments without the stress typically associated with conventional dental visits.

Regional Insights

North America was the largest region in the inhalation sedatives market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inhalation Sedatives Market?

The inhalation sedatives market consists of sales of halothane, fluticasone, budesonide, and ciclesonide. Values in this market are """"factory gate values,"""" that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Inhalation Sedatives Market Report 2026?

The inhalation sedatives market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation sedatives industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.